Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts — Stella

Home/Palmar or Plantar Warts/

View on ClinicalTrials.gov

Recruiting

Back to Palmar or Plantar Warts trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

France

Hospital Cochin, Paris

Key details

Phase

Large-scale testing

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~146 participants

Started

June 2022

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

15 Years and older

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.